EGFR and neoplasm: Surprisingly, compound 9c heightened the activation of ERK, probably due to the activation of alternative pathways in tumor cells resulting from the potent inhibition of EGFRs, as it has reported that the EGFR inhibitor causes the activation of ERK signaling mediated by SRC bypass [48].